Shares of Super Micro Computer slid another 11.4% to $8.82 on July 3, extending a punishing multi-week decline that has now erased roughly three-quarters of the stock's value since the company unveiled a massive equity raise on June 9. Supermicro announced $7.0 billion in equity and equity-linked financing transactions to fund the purchase of components to satisfy AI orders received in recent weeks. With no fresh company-specific catalyst today, the selloff reflects deepening investor unease over dilution — and a growing pile of legal troubles.
The Sheer Size of the Dilution Dwarfs the Company Itself. The combined equity and convertible issuance represents dilution equivalent to roughly 35% of Super Micro's pre-announcement market capitalization — meaning existing shareholders' slices of the pie shrink dramatically. The plan adds about $1.25 billion of new common stock immediately, up to $2 billion more through an at-the-market program starting as early as Q3 2026, and $3.75 billion of mandatory convertible preferred stock that becomes common stock around June 2029. That last tranche carries a 7.0% annual dividend, an expensive price tag for capital.
A $39 Billion Backlog Sounds Great — Until You Read the Fine Print. Supermicro says it received approximately $39 billion in AI server orders from more than 20 customers in recent weeks.
Investors will be watching whether the company can convert that backlog into revenue and margin growth quickly enough to justify the dilution. The company assembles liquid-cooled server racks for AI data centers but operates on thin hardware margins, so enormous revenue doesn't necessarily translate into enormous profit.
A Chip-Smuggling Probe Adds a Whole New Layer of Risk. Taiwanese prosecutors have escalated a criminal probe into alleged illegal exports of Nvidia AI chips to China, raiding Super Micro's Taiwan offices and detaining multiple employees.
The DOJ alleged a conspiracy to divert more than $2.5 billion in Nvidia AI servers to China, evading U.S. export controls. The U.S. trial is scheduled for November 2026 — a cloud that could linger for months.
The Market Has Already Rendered Its Verdict — For Now. SMCI shares fell 7.6% in after-hours trading on the announcement and sank 19.7% the next day to $32.35. From that already-battered level, the stock has now plunged to single digits. The market currently applies a persistent risk premium, necessitating caution ahead of the fiscal Q4 2026 earnings report in August — the first real test of whether $7 billion in shareholder pain is buying real growth or just buying time.